Elsevier, Journal of Affective Disorders, (163), p. 40-46, 2014
DOI: 10.1016/j.jad.2014.03.051
Full text: Download
Using data from the GenPod trial this study investigates: (i) if depressed individuals with multiple physical symptoms have a poorer response to antidepressants before and after adjustment for baseline Beck Depression Inventory II (BDI-II); and (ii) if reboxetine is more effective than citalopram in depression with multiple physical symptoms.